ANI PHARMACEUTICALS, INC Amortization of Intangible Assets
ANI PHARMACEUTICALS, INC (ANIP) reported Amortization of Intangible Assets of $17.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC amortization of intangible assets for the quarter ending 2026-06-30 was $17.40M, a 17.54% decline year-over-year.
- ANI PHARMACEUTICALS, INC amortization of intangible assets for the quarter ending 2026-03-31 was $18.70M, a 9.66% decline year-over-year.
- ANI PHARMACEUTICALS, INC amortization of intangible assets for the quarter ending 2025-12-31 was $20.30M, a 0.98% decline year-over-year.
- ANI PHARMACEUTICALS, INC amortization of intangible assets for the quarter ending 2025-09-30 was $20.40M, a 46.76% increase year-over-year.
- ANI PHARMACEUTICALS, INC amortization of intangible assets for fiscal 2025 was $82.50M, a 36.82% increase from fiscal 2024.
- ANI PHARMACEUTICALS, INC amortization of intangible assets for fiscal 2024 was $60.30M, a 15.30% increase from fiscal 2023.
- ANI PHARMACEUTICALS, INC amortization of intangible assets for fiscal 2023 was $52.30M, a 5.66% increase from fiscal 2022.
- ANI PHARMACEUTICALS, INC amortization of intangible assets for fiscal 2022 was $49.50M, a 18.42% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17.40M 10-Q · filed 2026-08-07 | $36.10M 10-Q · filed 2026-08-07 | $56.40M derived: sum of 3 quarters · filed 2026-08-07 | $76.80M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $18.70M 10-Q · filed 2026-05-08 | $39.00M derived: sum of 2 quarters · filed 2026-05-08 | $59.40M derived: sum of 3 quarters · filed 2026-05-08 | $80.50M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $20.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $40.70M derived: sum of 2 quarters · filed 2026-02-27 | $61.80M derived: sum of 3 quarters · filed 2026-08-07 | $82.50M 10-K · filed 2026-02-27 | ||
| 2025-09-30 | $20.40M 10-Q · filed 2025-11-07 | $41.50M derived: sum of 2 quarters · filed 2026-08-07 | $62.20M 10-Q · filed 2025-11-07 | $82.70M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $21.10M 10-Q · filed 2026-08-07 | $41.80M 10-Q · filed 2026-08-07 | $62.30M derived: sum of 3 quarters · filed 2026-08-07 | $76.20M derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $20.70M 10-Q · filed 2026-05-08 | $41.20M derived: sum of 2 quarters · filed 2026-05-08 | $55.10M derived: sum of 3 quarters · filed 2026-05-08 | $68.10M derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $20.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $34.40M derived: sum of 2 quarters · filed 2026-02-27 | $47.40M derived: sum of 3 quarters · filed 2026-02-27 | $60.30M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $13.90M 10-Q · filed 2025-11-07 | $26.90M derived: sum of 2 quarters · filed 2025-11-07 | $39.80M 10-Q · filed 2025-11-07 | $53.20M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-06-30 | $13.00M 10-Q · filed 2025-08-08 | $25.90M 10-Q · filed 2025-08-08 | $39.30M derived: sum of 3 quarters · filed 2026-02-27 | $52.60M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2024-03-31 | $13.00M 10-Q · filed 2025-05-09 | $26.30M derived: sum of 2 quarters · filed 2026-02-27 | $39.60M derived: sum of 3 quarters · filed 2026-02-27 | $52.40M derived: sum of 4 quarters · filed 2026-02-27 | ||
| 2023-12-31 | $13.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $26.60M derived: sum of 2 quarters · filed 2026-02-27 | $39.40M derived: sum of 3 quarters · filed 2026-02-27 | $52.30M 10-K · filed 2026-02-27 | ||
| 2023-09-30 | $13.30M 10-Q · filed 2024-11-08 | $26.10M derived: sum of 2 quarters · filed 2024-11-08 | $39.00M 10-Q · filed 2024-11-08 | $51.50M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $12.80M 10-Q · filed 2024-08-06 | $25.70M 10-Q · filed 2024-08-06 | $38.20M derived: sum of 3 quarters · filed 2025-02-28 | $50.70M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $12.80M 10-Q · filed 2024-05-10 | $25.40M derived: sum of 2 quarters · filed 2025-02-28 | $37.90M derived: sum of 3 quarters · filed 2025-02-28 | $49.80M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $12.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $25.10M derived: sum of 2 quarters · filed 2025-02-28 | $37.00M derived: sum of 3 quarters · filed 2025-02-28 | $49.50M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $12.50M 10-Q · filed 2023-11-08 | $24.40M derived: sum of 2 quarters · filed 2023-11-08 | $36.90M 10-Q · filed 2023-11-08 | $48.90M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $11.90M 10-Q · filed 2023-08-09 | $24.40M 10-Q · filed 2023-08-09 | $36.40M derived: sum of 3 quarters · filed 2024-02-29 | $46.50M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $12.50M 10-Q · filed 2023-05-08 | $24.50M derived: sum of 2 quarters · filed 2024-02-29 | $34.60M derived: sum of 3 quarters · filed 2024-02-29 | $44.70M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2021-12-31 | $12.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $22.10M derived: sum of 2 quarters · filed 2024-02-29 | $32.20M derived: sum of 3 quarters · filed 2024-02-29 | $41.80M 10-K · filed 2024-02-29 | ||
| 2021-09-30 | $10.10M 10-Q · filed 2022-11-09 | $20.20M derived: sum of 2 quarters · filed 2022-11-09 | $29.80M 10-Q · filed 2022-11-09 | $39.60M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-06-30 | $10.10M 10-Q · filed 2022-08-08 | $19.70M 10-Q · filed 2022-08-08 | $29.50M derived: sum of 3 quarters · filed 2023-03-09 | $39.60M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2021-03-31 | $9.70M 10-Q · filed 2022-05-10 | $19.40M derived: sum of 2 quarters · filed 2023-03-09 | $29.50M derived: sum of 3 quarters · filed 2023-03-09 | $39.50M derived: sum of 4 quarters · filed 2023-03-09 | ||
| 2020-12-31 | $9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $19.80M derived: sum of 2 quarters · filed 2023-03-09 | $29.80M derived: sum of 3 quarters · filed 2023-03-09 | $39.90M 10-K · filed 2023-03-09 | ||
| 2020-09-30 | $10.10M 10-Q · filed 2021-11-01 | $20.10M derived: sum of 2 quarters · filed 2021-11-01 | $30.20M 10-Q · filed 2021-11-01 | $38.50M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-06-30 | $10.00M 10-Q · filed 2021-08-06 | $20.10M 10-Q · filed 2021-08-06 | $28.40M derived: sum of 3 quarters · filed 2022-03-15 | $36.80M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2020-03-31 | $10.00M 10-Q · filed 2021-05-07 | $18.40M derived: sum of 2 quarters · filed 2022-03-15 | $26.80M derived: sum of 3 quarters · filed 2022-03-15 | $35.20M derived: sum of 4 quarters · filed 2022-03-15 | ||
| 2019-12-31 | $8.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $16.80M derived: sum of 2 quarters · filed 2022-03-15 | $25.20M derived: sum of 3 quarters · filed 2022-03-15 | $40.20M 10-K · filed 2022-03-15 | ||
| 2019-09-30 | $8.40M 10-Q · filed 2020-11-05 | $16.80M derived: sum of 2 quarters · filed 2020-11-05 | $31.80M 10-Q · filed 2020-11-05 | $39.80M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-06-30 | $8.40M 10-Q · filed 2020-08-06 | $23.40M 10-Q · filed 2020-08-06 | $31.40M derived: sum of 3 quarters · filed 2021-03-11 | $39.30M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2019-03-31 | $15.00M 10-Q · filed 2020-05-07 | $23.00M derived: sum of 2 quarters · filed 2021-03-11 | $30.90M derived: sum of 3 quarters · filed 2021-03-11 | $38.80M derived: sum of 4 quarters · filed 2021-03-11 | ||
| 2018-12-31 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $15.90M derived: sum of 2 quarters · filed 2021-03-11 | $23.80M derived: sum of 3 quarters · filed 2021-03-11 | $31.70M 10-K · filed 2021-03-11 | ||
| 2018-09-30 | $7.90M 10-Q · filed 2019-11-06 | $15.80M derived: sum of 2 quarters · filed 2019-11-06 | $23.70M 10-Q · filed 2019-11-06 | $30.40M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-06-30 | $7.90M 10-Q · filed 2019-08-07 | $15.80M 10-Q · filed 2019-08-07 | $22.50M derived: sum of 3 quarters · filed 2020-02-27 | $29.30M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $7.90M 10-Q · filed 2019-05-09 | $14.60M derived: sum of 2 quarters · filed 2020-02-27 | $21.40M derived: sum of 3 quarters · filed 2020-02-27 | $28.20M derived: sum of 4 quarters · filed 2020-02-27 | ||
| 2017-12-31 | $6.70M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $13.50M derived: sum of 2 quarters · filed 2020-02-27 | $20.30M derived: sum of 3 quarters · filed 2020-02-27 | $26.70M 10-K · filed 2020-02-27 | ||
| 2017-09-30 | $6.80M 10-Q · filed 2018-11-06 | $13.60M derived: sum of 2 quarters · filed 2018-11-06 | $20.00M 10-Q · filed 2018-11-06 | $25.60M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-06-30 | $6.80M 10-Q · filed 2017-08-03 | $13.20M 10-Q · filed 2018-08-07 | $18.80M derived: sum of 3 quarters · filed 2019-02-27 | $24.50M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2017-03-31 | $6.40M 10-Q · filed 2018-05-08 | $12.00M derived: sum of 2 quarters · filed 2019-02-27 | $17.70M derived: sum of 3 quarters · filed 2019-02-27 | $23.40M derived: sum of 4 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $11.30M derived: sum of 2 quarters · filed 2019-02-27 | $17.00M derived: sum of 3 quarters · filed 2019-02-27 | $21.40M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | $5.70M 10-Q · filed 2017-11-02 | $11.40M derived: sum of 2 quarters · filed 2017-11-02 | $15.80M 10-Q · filed 2017-11-02 | $17.70M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-06-30 | $5.70M 10-Q · filed 2017-08-03 | $10.10M 10-Q · filed 2017-08-03 | $12.00M derived: sum of 3 quarters · filed 2018-02-27 | $13.90M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-03-31 | $4.40M 10-Q · filed 2017-05-04 | $6.30M derived: sum of 2 quarters · filed 2018-02-27 | $8.20M derived: sum of 3 quarters · filed 2018-02-27 | $9.40M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $3.80M derived: sum of 2 quarters · filed 2018-02-27 | $5.00M derived: sum of 3 quarters · filed 2018-02-27 | $6.20M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $1.90M 10-Q · filed 2016-11-03 | $3.10M derived: sum of 2 quarters · filed 2016-11-03 | $4.30M 10-Q · filed 2016-11-03 | $5.40M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2015-06-30 | $1.20M 10-Q · filed 2016-08-04 | $2.40M 10-Q · filed 2016-08-04 | $3.50M derived: sum of 3 quarters · filed 2017-03-02 | $4.50M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2015-03-31 | $1.20M 10-Q · filed 2016-05-05 | $2.30M derived: sum of 2 quarters · filed 2017-03-02 | $3.30M derived: sum of 3 quarters · filed 2017-03-02 | $3.90M derived: sum of 4 quarters · filed 2017-03-02 | ||
| 2014-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $2.10M derived: sum of 2 quarters · filed 2017-03-02 | $2.70M derived: sum of 3 quarters · filed 2017-03-02 | $3.30M 10-K · filed 2017-03-02 | ||
| 2014-09-30 | $1.00M 10-Q · filed 2015-11-03 | $1.60M derived: sum of 2 quarters · filed 2015-11-03 | $2.20M 10-Q · filed 2015-11-03 | $2.50M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-06-30 | $600.00K 10-Q · filed 2015-08-04 | $1.10M 10-Q · filed 2015-08-04 | $1.50M derived: sum of 3 quarters · filed 2016-02-23 | $1.70M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2014-03-31 | $600.00K 10-Q · filed 2015-05-05 | $900.00K derived: sum of 2 quarters · filed 2016-02-23 | $1.10M derived: sum of 3 quarters · filed 2016-02-23 | $1.11M derived: sum of 4 quarters · filed 2016-02-23 | ||
| 2013-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $500.00K derived: sum of 2 quarters · filed 2016-02-23 | $513.00K derived: sum of 3 quarters · filed 2016-02-23 | $600.00K 10-K · filed 2016-02-23 | ||
| 2013-09-30 | $200.00K 10-Q · filed 2014-11-10 | $247.73K 10-Q · filed 2013-11-07 | $213.00K derived: sum of 2 quarters · filed 2014-11-10 | $300.00K 10-Q · filed 2014-11-10 | $272.73K 10-Q · filed 2013-11-07 | $238.50K derived: sum of 4 quarters · filed 2014-11-10 |
| 2013-06-30 | $13.00K 10-Q · filed 2014-08-07 | $12.50K 10-Q · filed 2013-08-09 | $25.00K 10-Q · filed 2014-08-07 | $38.50K derived: sum of 3 quarters · filed 2014-08-07 | $51.00K derived: sum of 4 quarters · filed 2014-08-07 | |
| 2013-03-31 | $13.00K 10-Q · filed 2014-05-12 | $25.50K derived: sum of 2 quarters · filed 2014-05-12 | $38.00K derived: sum of 3 quarters · filed 2014-05-12 | $50.50K derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $12.50K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $25.00K derived: sum of 2 quarters · filed 2014-02-28 | $37.50K derived: sum of 3 quarters · filed 2014-02-28 | $50.00K 10-K · filed 2014-02-28 | ||
| 2012-09-30 | $12.50K 10-Q · filed 2013-11-07 | $25.00K derived: sum of 2 quarters · filed 2013-11-07 | $37.50K 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $12.50K 10-Q · filed 2013-08-09 | $25.00K 10-Q · filed 2013-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |